Cardiology
Conference Coverage
CABANA: Ablation surpassed drugs for raising AF quality of life
Conference Coverage
Lessons learned from the PCSK9 inhibitor trials
LOS ANGELES – The higher your risk, the greater your benefit from therapeutic intervention.
Audio
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
.
From the Journals
Meta-analysis supports aspirin to reduce cardiovascular events
A review of randomized trials shows benefits for preventing cardiovascular disease, but at cost of increased bleeding risk.
Conference Coverage
Subclinical hypothyroidism boosts immediate risk of heart failure
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.
Conference Coverage
Ezetimibe found effective for primary prevention in elderly
CHICAGO – Japanese EWTOPIA 75 study provides first RCT evidence of benefit for LDL-lowering in seniors.
Audio
Sleep: Too much, too little both tied to atherosclerosis
Plus, a possible prognostic marker for heart failure, a new class of cholesterol drugs emerges, and more.
Conference Coverage
Obesity paradox applies to post-stroke mortality
From the Journals
Treat-to-target approach for CVD risk factors decreased atherosclerosis in RA patients
An open-label, randomized, controlled trial looked at the progression of carotid intima media thickness in addition to cardiovascular events.
Conference Coverage
Novel agent cut LDL in statin-intolerant patients
CHICAGO – Bempedoic acid will also be tested in combination with ezetimibe in a single pill.
Conference Coverage
Impact of carbs vs. fats on CVD risk becoming better understood
LOS ANGELES – Risk measures can be improved by lowering dietary carbohydrates, not by lowering saturated fats.